Differential Effects of Trp53 Alterations in Murine Colorectal Cancer

Colorectal cancer (CRC) development is a multi-step process resulting in the accumulation of genetic alterations. Despite its high incidence, there are currently no mouse models that accurately recapitulate this process and mimic sporadic CRC. We aimed to develop and characterize a genetically engin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2021-02, Vol.13 (4), p.808
Hauptverfasser: Betzler, Alexander M, Nanduri, Lahiri K, Hissa, Barbara, Blickensdörfer, Linda, Muders, Michael H, Roy, Janine, Jesinghaus, Moritz, Steiger, Katja, Weichert, Wilko, Kloor, Matthias, Klink, Barbara, Schroeder, Michael, Mazzone, Massimiliano, Weitz, Jürgen, Reissfelder, Christoph, Rahbari, Nuh N, Schölch, Sebastian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 808
container_title Cancers
container_volume 13
creator Betzler, Alexander M
Nanduri, Lahiri K
Hissa, Barbara
Blickensdörfer, Linda
Muders, Michael H
Roy, Janine
Jesinghaus, Moritz
Steiger, Katja
Weichert, Wilko
Kloor, Matthias
Klink, Barbara
Schroeder, Michael
Mazzone, Massimiliano
Weitz, Jürgen
Reissfelder, Christoph
Rahbari, Nuh N
Schölch, Sebastian
description Colorectal cancer (CRC) development is a multi-step process resulting in the accumulation of genetic alterations. Despite its high incidence, there are currently no mouse models that accurately recapitulate this process and mimic sporadic CRC. We aimed to develop and characterize a genetically engineered mouse model (GEMM) of Apc/Kras/Trp53 mutant CRC, the most frequent genetic subtype of CRC. Tumors were induced in mice with conditional mutations or knockouts in Apc, Kras, and Trp53 by a segmental adeno-cre viral infection, monitored via colonoscopy and characterized on multiple levels via immunohistochemistry and next-generation sequencing. The model accurately recapitulates human colorectal carcinogenesis clinically, histologically and genetically. The Trp53 R172H hotspot mutation leads to significantly increased metastatic capacity. The effects of Trp53 alterations, as well as the response to treatment of this model, are similar to human CRC. Exome sequencing revealed spontaneous protein-modifying alterations in multiple CRC-related genes and oncogenic pathways, resulting in a genetic landscape resembling human CRC. This model realistically mimics human CRC in many aspects, allows new insights into the role of TP53 in CRC, enables highly predictive preclinical studies and demonstrates the value of GEMMs in current translational cancer research and drug development.
doi_str_mv 10.3390/cancers13040808
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7919037</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2491628167</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-5d1b86abff58e9059aa1235ad3e168527520797ef1277debe435e218a379052f3</originalsourceid><addsrcrecordid>eNpdkM9LwzAYhoMobsydvUnB81ySr02aizDq_AETL_Mc0jbRjK6ZSSv435u5Oaa55IM835uHF6FLgm8ABJ5Wqq20DwRwinOcn6AhxZxOGBPp6dE8QOMQVjgeAMIZP0cDAMaJADpE8ztrjPa67axqknmcqy4kziRLv8kgmTWd9qqzrg2JbZPn3ttWJ4VrnI9g3Ch-HC7QmVFN0OP9PUKv9_Nl8ThZvDw8FbPFpEop6SZZTcqcqdKYLNcCZ0IpQiFTNWjC8ozyLEoLrg2hnNe61ClkmpJcAY80NTBCt7vcTV-udV1Fba8aufF2rfyXdMrKvy-tfZdv7lNyQQQGHgOu9wHeffQ6dHLlet9GZ0lTQRjNCdtS0x1VeReC1-bwA8FyW738V33cuDoWO_C_RcM3-uN_7A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2491628167</pqid></control><display><type>article</type><title>Differential Effects of Trp53 Alterations in Murine Colorectal Cancer</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Betzler, Alexander M ; Nanduri, Lahiri K ; Hissa, Barbara ; Blickensdörfer, Linda ; Muders, Michael H ; Roy, Janine ; Jesinghaus, Moritz ; Steiger, Katja ; Weichert, Wilko ; Kloor, Matthias ; Klink, Barbara ; Schroeder, Michael ; Mazzone, Massimiliano ; Weitz, Jürgen ; Reissfelder, Christoph ; Rahbari, Nuh N ; Schölch, Sebastian</creator><creatorcontrib>Betzler, Alexander M ; Nanduri, Lahiri K ; Hissa, Barbara ; Blickensdörfer, Linda ; Muders, Michael H ; Roy, Janine ; Jesinghaus, Moritz ; Steiger, Katja ; Weichert, Wilko ; Kloor, Matthias ; Klink, Barbara ; Schroeder, Michael ; Mazzone, Massimiliano ; Weitz, Jürgen ; Reissfelder, Christoph ; Rahbari, Nuh N ; Schölch, Sebastian</creatorcontrib><description>Colorectal cancer (CRC) development is a multi-step process resulting in the accumulation of genetic alterations. Despite its high incidence, there are currently no mouse models that accurately recapitulate this process and mimic sporadic CRC. We aimed to develop and characterize a genetically engineered mouse model (GEMM) of Apc/Kras/Trp53 mutant CRC, the most frequent genetic subtype of CRC. Tumors were induced in mice with conditional mutations or knockouts in Apc, Kras, and Trp53 by a segmental adeno-cre viral infection, monitored via colonoscopy and characterized on multiple levels via immunohistochemistry and next-generation sequencing. The model accurately recapitulates human colorectal carcinogenesis clinically, histologically and genetically. The Trp53 R172H hotspot mutation leads to significantly increased metastatic capacity. The effects of Trp53 alterations, as well as the response to treatment of this model, are similar to human CRC. Exome sequencing revealed spontaneous protein-modifying alterations in multiple CRC-related genes and oncogenic pathways, resulting in a genetic landscape resembling human CRC. This model realistically mimics human CRC in many aspects, allows new insights into the role of TP53 in CRC, enables highly predictive preclinical studies and demonstrates the value of GEMMs in current translational cancer research and drug development.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers13040808</identifier><identifier>PMID: 33671932</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adenomatous polyposis coli ; Animal models ; Cancer ; Carcinogenesis ; Cell adhesion &amp; migration ; Colonoscopy ; Colorectal cancer ; Colorectal carcinoma ; Drug development ; Experiments ; Genetic engineering ; Histology ; Immunohistochemistry ; Infections ; Laboratories ; Metastases ; Metastasis ; Mutation ; Mutation hot spots ; Next-generation sequencing ; p53 Protein ; Survival analysis ; Tumors</subject><ispartof>Cancers, 2021-02, Vol.13 (4), p.808</ispartof><rights>2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-5d1b86abff58e9059aa1235ad3e168527520797ef1277debe435e218a379052f3</citedby><cites>FETCH-LOGICAL-c421t-5d1b86abff58e9059aa1235ad3e168527520797ef1277debe435e218a379052f3</cites><orcidid>0000-0002-7269-5433 ; 0000-0003-0012-3177 ; 0000-0003-4591-1046 ; 0000-0002-0258-6055</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919037/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919037/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33671932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Betzler, Alexander M</creatorcontrib><creatorcontrib>Nanduri, Lahiri K</creatorcontrib><creatorcontrib>Hissa, Barbara</creatorcontrib><creatorcontrib>Blickensdörfer, Linda</creatorcontrib><creatorcontrib>Muders, Michael H</creatorcontrib><creatorcontrib>Roy, Janine</creatorcontrib><creatorcontrib>Jesinghaus, Moritz</creatorcontrib><creatorcontrib>Steiger, Katja</creatorcontrib><creatorcontrib>Weichert, Wilko</creatorcontrib><creatorcontrib>Kloor, Matthias</creatorcontrib><creatorcontrib>Klink, Barbara</creatorcontrib><creatorcontrib>Schroeder, Michael</creatorcontrib><creatorcontrib>Mazzone, Massimiliano</creatorcontrib><creatorcontrib>Weitz, Jürgen</creatorcontrib><creatorcontrib>Reissfelder, Christoph</creatorcontrib><creatorcontrib>Rahbari, Nuh N</creatorcontrib><creatorcontrib>Schölch, Sebastian</creatorcontrib><title>Differential Effects of Trp53 Alterations in Murine Colorectal Cancer</title><title>Cancers</title><addtitle>Cancers (Basel)</addtitle><description>Colorectal cancer (CRC) development is a multi-step process resulting in the accumulation of genetic alterations. Despite its high incidence, there are currently no mouse models that accurately recapitulate this process and mimic sporadic CRC. We aimed to develop and characterize a genetically engineered mouse model (GEMM) of Apc/Kras/Trp53 mutant CRC, the most frequent genetic subtype of CRC. Tumors were induced in mice with conditional mutations or knockouts in Apc, Kras, and Trp53 by a segmental adeno-cre viral infection, monitored via colonoscopy and characterized on multiple levels via immunohistochemistry and next-generation sequencing. The model accurately recapitulates human colorectal carcinogenesis clinically, histologically and genetically. The Trp53 R172H hotspot mutation leads to significantly increased metastatic capacity. The effects of Trp53 alterations, as well as the response to treatment of this model, are similar to human CRC. Exome sequencing revealed spontaneous protein-modifying alterations in multiple CRC-related genes and oncogenic pathways, resulting in a genetic landscape resembling human CRC. This model realistically mimics human CRC in many aspects, allows new insights into the role of TP53 in CRC, enables highly predictive preclinical studies and demonstrates the value of GEMMs in current translational cancer research and drug development.</description><subject>Adenomatous polyposis coli</subject><subject>Animal models</subject><subject>Cancer</subject><subject>Carcinogenesis</subject><subject>Cell adhesion &amp; migration</subject><subject>Colonoscopy</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Drug development</subject><subject>Experiments</subject><subject>Genetic engineering</subject><subject>Histology</subject><subject>Immunohistochemistry</subject><subject>Infections</subject><subject>Laboratories</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Mutation</subject><subject>Mutation hot spots</subject><subject>Next-generation sequencing</subject><subject>p53 Protein</subject><subject>Survival analysis</subject><subject>Tumors</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkM9LwzAYhoMobsydvUnB81ySr02aizDq_AETL_Mc0jbRjK6ZSSv435u5Oaa55IM835uHF6FLgm8ABJ5Wqq20DwRwinOcn6AhxZxOGBPp6dE8QOMQVjgeAMIZP0cDAMaJADpE8ztrjPa67axqknmcqy4kziRLv8kgmTWd9qqzrg2JbZPn3ttWJ4VrnI9g3Ch-HC7QmVFN0OP9PUKv9_Nl8ThZvDw8FbPFpEop6SZZTcqcqdKYLNcCZ0IpQiFTNWjC8ozyLEoLrg2hnNe61ClkmpJcAY80NTBCt7vcTV-udV1Fba8aufF2rfyXdMrKvy-tfZdv7lNyQQQGHgOu9wHeffQ6dHLlet9GZ0lTQRjNCdtS0x1VeReC1-bwA8FyW738V33cuDoWO_C_RcM3-uN_7A</recordid><startdate>20210215</startdate><enddate>20210215</enddate><creator>Betzler, Alexander M</creator><creator>Nanduri, Lahiri K</creator><creator>Hissa, Barbara</creator><creator>Blickensdörfer, Linda</creator><creator>Muders, Michael H</creator><creator>Roy, Janine</creator><creator>Jesinghaus, Moritz</creator><creator>Steiger, Katja</creator><creator>Weichert, Wilko</creator><creator>Kloor, Matthias</creator><creator>Klink, Barbara</creator><creator>Schroeder, Michael</creator><creator>Mazzone, Massimiliano</creator><creator>Weitz, Jürgen</creator><creator>Reissfelder, Christoph</creator><creator>Rahbari, Nuh N</creator><creator>Schölch, Sebastian</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7269-5433</orcidid><orcidid>https://orcid.org/0000-0003-0012-3177</orcidid><orcidid>https://orcid.org/0000-0003-4591-1046</orcidid><orcidid>https://orcid.org/0000-0002-0258-6055</orcidid></search><sort><creationdate>20210215</creationdate><title>Differential Effects of Trp53 Alterations in Murine Colorectal Cancer</title><author>Betzler, Alexander M ; Nanduri, Lahiri K ; Hissa, Barbara ; Blickensdörfer, Linda ; Muders, Michael H ; Roy, Janine ; Jesinghaus, Moritz ; Steiger, Katja ; Weichert, Wilko ; Kloor, Matthias ; Klink, Barbara ; Schroeder, Michael ; Mazzone, Massimiliano ; Weitz, Jürgen ; Reissfelder, Christoph ; Rahbari, Nuh N ; Schölch, Sebastian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-5d1b86abff58e9059aa1235ad3e168527520797ef1277debe435e218a379052f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adenomatous polyposis coli</topic><topic>Animal models</topic><topic>Cancer</topic><topic>Carcinogenesis</topic><topic>Cell adhesion &amp; migration</topic><topic>Colonoscopy</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Drug development</topic><topic>Experiments</topic><topic>Genetic engineering</topic><topic>Histology</topic><topic>Immunohistochemistry</topic><topic>Infections</topic><topic>Laboratories</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Mutation</topic><topic>Mutation hot spots</topic><topic>Next-generation sequencing</topic><topic>p53 Protein</topic><topic>Survival analysis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Betzler, Alexander M</creatorcontrib><creatorcontrib>Nanduri, Lahiri K</creatorcontrib><creatorcontrib>Hissa, Barbara</creatorcontrib><creatorcontrib>Blickensdörfer, Linda</creatorcontrib><creatorcontrib>Muders, Michael H</creatorcontrib><creatorcontrib>Roy, Janine</creatorcontrib><creatorcontrib>Jesinghaus, Moritz</creatorcontrib><creatorcontrib>Steiger, Katja</creatorcontrib><creatorcontrib>Weichert, Wilko</creatorcontrib><creatorcontrib>Kloor, Matthias</creatorcontrib><creatorcontrib>Klink, Barbara</creatorcontrib><creatorcontrib>Schroeder, Michael</creatorcontrib><creatorcontrib>Mazzone, Massimiliano</creatorcontrib><creatorcontrib>Weitz, Jürgen</creatorcontrib><creatorcontrib>Reissfelder, Christoph</creatorcontrib><creatorcontrib>Rahbari, Nuh N</creatorcontrib><creatorcontrib>Schölch, Sebastian</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Betzler, Alexander M</au><au>Nanduri, Lahiri K</au><au>Hissa, Barbara</au><au>Blickensdörfer, Linda</au><au>Muders, Michael H</au><au>Roy, Janine</au><au>Jesinghaus, Moritz</au><au>Steiger, Katja</au><au>Weichert, Wilko</au><au>Kloor, Matthias</au><au>Klink, Barbara</au><au>Schroeder, Michael</au><au>Mazzone, Massimiliano</au><au>Weitz, Jürgen</au><au>Reissfelder, Christoph</au><au>Rahbari, Nuh N</au><au>Schölch, Sebastian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential Effects of Trp53 Alterations in Murine Colorectal Cancer</atitle><jtitle>Cancers</jtitle><addtitle>Cancers (Basel)</addtitle><date>2021-02-15</date><risdate>2021</risdate><volume>13</volume><issue>4</issue><spage>808</spage><pages>808-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Colorectal cancer (CRC) development is a multi-step process resulting in the accumulation of genetic alterations. Despite its high incidence, there are currently no mouse models that accurately recapitulate this process and mimic sporadic CRC. We aimed to develop and characterize a genetically engineered mouse model (GEMM) of Apc/Kras/Trp53 mutant CRC, the most frequent genetic subtype of CRC. Tumors were induced in mice with conditional mutations or knockouts in Apc, Kras, and Trp53 by a segmental adeno-cre viral infection, monitored via colonoscopy and characterized on multiple levels via immunohistochemistry and next-generation sequencing. The model accurately recapitulates human colorectal carcinogenesis clinically, histologically and genetically. The Trp53 R172H hotspot mutation leads to significantly increased metastatic capacity. The effects of Trp53 alterations, as well as the response to treatment of this model, are similar to human CRC. Exome sequencing revealed spontaneous protein-modifying alterations in multiple CRC-related genes and oncogenic pathways, resulting in a genetic landscape resembling human CRC. This model realistically mimics human CRC in many aspects, allows new insights into the role of TP53 in CRC, enables highly predictive preclinical studies and demonstrates the value of GEMMs in current translational cancer research and drug development.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>33671932</pmid><doi>10.3390/cancers13040808</doi><orcidid>https://orcid.org/0000-0002-7269-5433</orcidid><orcidid>https://orcid.org/0000-0003-0012-3177</orcidid><orcidid>https://orcid.org/0000-0003-4591-1046</orcidid><orcidid>https://orcid.org/0000-0002-0258-6055</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2021-02, Vol.13 (4), p.808
issn 2072-6694
2072-6694
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7919037
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central
subjects Adenomatous polyposis coli
Animal models
Cancer
Carcinogenesis
Cell adhesion & migration
Colonoscopy
Colorectal cancer
Colorectal carcinoma
Drug development
Experiments
Genetic engineering
Histology
Immunohistochemistry
Infections
Laboratories
Metastases
Metastasis
Mutation
Mutation hot spots
Next-generation sequencing
p53 Protein
Survival analysis
Tumors
title Differential Effects of Trp53 Alterations in Murine Colorectal Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T08%3A54%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20Effects%20of%20Trp53%20Alterations%20in%20Murine%20Colorectal%20Cancer&rft.jtitle=Cancers&rft.au=Betzler,%20Alexander%20M&rft.date=2021-02-15&rft.volume=13&rft.issue=4&rft.spage=808&rft.pages=808-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers13040808&rft_dat=%3Cproquest_pubme%3E2491628167%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2491628167&rft_id=info:pmid/33671932&rfr_iscdi=true